The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
A large number of studies have been published over the last two decades examining molecular mechanisms of antifungal resistance in Candida species. However, few of these studies have explored how such mechanisms influence the host immune response to this opportunistic pathogen. With recent advances in our understanding of host immunity to Candida, a body of emerging literature has begun to explore how intrinsic and adaptive resistance mechanisms in Candida alter host immune system evasion and detection, which could have important implications for understanding (1) why certain resistance mechanisms and Candida species predominate in certain patient populations, (2) the biological context for understanding why high in vitro levels of resistance in may not necessarily correlate with risk of drug failure in vivo and (3) insight into effective immunotherapeutic strategies for combatting Candida resistance. Although this area of research is still in its infancy, two themes are emerging: First, the immunoevasion and intracellular persistence of C. glabrata may be a key factor in the capability of this species to persist in the course of multiple antifungal treatments and develop multidrug resistance. Second, changes in the cell wall associated with antifungal resistance often favor evasion for the host immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 3×
“Amphotericin B resistance in Candida is generally assumed to be rare, although many broth-based methods used for detecting resistance in Candida species may lack the sensitivity to reliably detect resistance in vitro.(4) Candida species for which MICs .”
BackgroundPappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793
Pappas, P. G., Alexander, B. D., Andes, D. R., Hadley, S., Kauffman, C. A., Freifeld, A., Anaissie, E. J., Brumble, L. M., Herwaldt, L., Ito, J., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651262 · Cited by 1,570
Self-citationDenning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131 · cited 1×
“Despite some pharmacokinetic differences, all three echinocandins act by inhibiting 1,3-β-D-glucan synthase, thereby disrupting glucan biosynthesis in the cell wall.(55) Candida cells exposed to echinocandin concentrations near the MIC have defective cell walls that render the cell susceptible to osmotic lysis.”
BackgroundHorn, D. L., Neofytos, D., Anaissie, E. J., Fishman, J. A., Steinbach, W. J., Olyaei, A. J., Marr, K. A., Pfaller, M. A., Chang, C., & Webster, K. M. (2009) · Clinical Infectious Diseases · doi:10.1086/599039 · Cited by 956 · cited 1×
“The ubiquity of these risk factors explains, in part, the continuing high prevalence of Candida infections in cancer, transplant and ICU patient populations.(2,3) Although the prompt administration of effective systemic antifungal therapy can significantly reduce the morbidity and mortality associated with invasive ca…”
BackgroundFidel, P. L., Vazquez, J. A., & Sobel, J. D. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.80 · Cited by 953
An integrated model of the recognition of Candida albicans by the innate immune system
Netea, M. G., Brown, G. D., Kullberg, B. J., & Gow, N. A. R. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1815 · Cited by 946 · cited 4×
“In contrast, hyphal forms of Candida preferentially activate TLR2, which induce a much weaker TH1-response, thus promoting conditions favorable for a TH2 or T-regulatory cell expansion driven by IL-10 that in experimental infections models is associated with reduced Candida clearance.(9,13,14) Hence, the shift from th…”
BackgroundInfluentialAntifungal drug resistance: mechanisms, epidemiology, and consequences for treatment
Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903
Epidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
Candida albicans morphogenesis and host defence: discriminating invasion from colonization
Gow, N. A. R., van de Veerdonk, F. L., Brown, A. J. P., & Netea, M. G. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2711 · Cited by 888 · cited 11×
“The yeast to hyphal transition is also associated with marked changes in the organization of cell wall carbohydrates and proteins.(8) The cell wall of C.”
BackgroundMethodInfluentialPfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718
A Recently Evolved Transcriptional Network Controls Biofilm Development in Candida albicans
Nobile, C. J., Fox, E. P., Nett, J. E., Sorrells, T. R., Mitrovich, Q. M., Hernday, A. D., Tuch, B. B., Andes, D. R., & Johnson, A. D. (2012) · Cell · doi:10.1016/j.cell.2011.10.048 · Cited by 711
Ramage, G. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf049 · Cited by 468
Stimulation of Chitin Synthesis Rescues Candida albicans from Echinocandins
Walker, L. A., Munro, C. A., de Bruijn, I., Lenardon, M. D., McKinnon, A., & Gow, N. A. R. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000040 · Cited by 445 · cited 1×
“Interestingly, compensatory increases in cell wall chitin synthesis were also found to be a good indicator if which stain display paradoxical growth at high echinocandin concentrations.(65) The investigators were able to demonstrate that chitin purified from Candida albicans cell wall blocked Dectin-1 mediated recogni…”
BackgroundPutative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance
Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., VanHandel, M., & Andes, D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01056-06 · Cited by 407
Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition
Silva, S., Henriques, M., Martins, A., Oliveira, R., Williams, D., & Azeredo, J. (2009) · Medical Mycology · doi:10.3109/13693780802549594 · Cited by 390 · cited 1×
“Recent evidence suggest that β-1,3-glucans are a major component of Candida biofilms and may directly bind triazole antifungals such as fluconazole.(41,43) Because drug efflux pumps are upregulated when cells grow in biofilm condition,(44) it is possible that selection of mutants overexpressing efflux mechanisms durin…”
BackgroundPfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377
Evolution of antifungal-drug resistance: mechanisms and pathogen fitness
Anderson, J. B. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1179 · Cited by 375 · cited 1×
“The concept for this figure was derived from review by James Anderson.(80)”
MethodLiu, T. T., Lee, R. E. B., Barker, K. S., Lee, R. E., Wei, L., Homayouni, R., & Rogers, P. D. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2226-2236.2005 · Cited by 313
Dynamic, Morphotype-Specific Candida albicans β-Glucan Exposure during Infection and Drug Treatment
Wheeler, R. T., Kombe, D., Agarwala, S. D., & Fink, G. R. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000227 · Cited by 309
Ferrari, S., Ischer, F., Calabrese, D., Posteraro, B., Sanguinetti, M., Fadda, G., Rohde, B., Bauser, C., Bader, O., & Sanglard, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000268 · Cited by 295 · cited 1×
“glabrata, was associated not only with higher levels of in vitro/in vivo resistance to fluconazole, but also increased virulence and “dominance” of the fungal population in mice even in the absence of drug selection.(49,50) Enhanced in vivo virulence has also been reported in other fluconazole-resistant C.”
BackgroundHsp90 Governs Dispersion and Drug Resistance of Fungal Biofilms
Robbins, N., Uppuluri, P., Nett, J., Rajendran, R., Ramage, G., Lopez-Ribot, J. L., Andes, D., & Cowen, L. E. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002257 · Cited by 291
Current Perspectives on Echinocandin Class Drugs
Perlin, D. S. (2011) · Future Microbiology · doi:10.2217/fmb.11.19 · Cited by 274 · cited 1×
“glabrata.(60) Mutations in the FKS catalytic subunits alter the kinetics of the glucan synthase enzyme complex resulting in higher inhibitory constant 50% (IC50) and a 50- to several thousand-fold increased kinetic inhibition (ki) for the mutant enzymes for all three echinocandins compared with sensitive wild-type str…”
BackgroundA yeast by any other name: Candida glabrata and its interaction with the host
Kaur, R., Domergue, R., Zupancic, M. L., & Cormack, B. P. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.06.012 · Cited by 271
Fungal echinocandin resistance
Walker, L. A., Gow, N. A. R., & Munro, C. A. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.09.003 · Cited by 267
Sanglard, D., Ischer, F., & Bille, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1174-1183.2001 · Cited by 247
Seider, K., Brunke, S., Schild, L., Jablonowski, N., Wilson, D., Majer, O., Barz, D., Haas, A., Kuchler, K., Schaller, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003730 · Cited by 220 · cited 3×
“glabrata was able to subvert normal macrophage phagosome maturation, survive and replicate within these immune cells for considerable periods of time without damaging the host cell or eliciting a proinflammatory immune response.(26) While this interaction could be mutually beneficial during commensal carriage, it woul…”
BackgroundInfluentialElevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo
Lee, K. K., MacCallum, D. M., Jacobsen, M. D., Walker, L. A., Odds, F. C., Gow, N. A. R., & Munro, C. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00683-11 · Cited by 209 · cited 3×
“The investigators were able to demonstrate that chitin purified from Candida albicans cell wall blocked Dectin-1 mediated recognition of human peripheral blood mononuclear cells and murine macrophages, leading to significant reductions in cytokine production.(76) Hence, chitin may be a signature of “less invasive” for…”
BackgroundNett, J. E., Crawford, K., Marchillo, K., & Andes, D. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00227-10 · Cited by 207 · cited 1×
“Because drug efflux pumps are upregulated when cells grow in biofilm condition,(44) it is possible that selection of mutants overexpressing efflux mechanisms during drug therapy may favor biofilm-oriented growth and escape from the host immune system.(42,45,46) Several studies have surveyed the impact of these acquire…”
BackgroundStevens, D. A., Ichinomiya, M., Koshi, Y., & Horiuchi, H. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00563-06 · Cited by 193
Cheng, S.-C., van de Veerdonk, F. L., Lenardon, M., Stoffels, M., Plantinga, T., Smeekens, S., Rizzetto, L., Mukaremera, L., Preechasuth, K., Cavalieri, D., et al. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1210702 · Cited by 191
Pfaller, M. A., Espinel-Ingroff, A., Canton, E., Castanheira, M., Cuenca-Estrella, M., Diekema, D. J., Fothergill, A., Fuller, J., Ghannoum, M., Jones, R. N., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00248-12 · Cited by 174 · cited 1×
“1 mg/L are unusual, but at the very least, may require higher doses of amphotericin B for optimal treatment.(4,31) Compared with C.”
BackgroundInteraction of pathogenic yeasts with phagocytes: survival, persistence and escape.
Seider, K., Heyken, A., Lüttich, A., Miramón, P., & Hube, B. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.05.001 · Cited by 167
Ben-Ami, R., Garcia-Effron, G., Lewis, R. E., Gamarra, S., Leventakos, K., Perlin, D. S., & Kontoyiannis, D. P. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir351 · Cited by 162
Self-citationFerrari, S., Sanguinetti, M., De Bernardis, F., Torelli, R., Posteraro, B., Vandeputte, P., & Sanglard, D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01271-10 · Cited by 144 · cited 2×
“glabrata isolates selected in vivo where triazole resistance developed from mitochondrial DNA deficiency independent of gain-of-function mutations in drug efflux pumps.(49) Interestingly, these petite mutants displayed enhanced expression of stress response pathways and cell wall remodeling, similar to that reported a…”
BackgroundResultWiederhold, N. P., Kontoyiannis, D. P., Prince, R. A., & Lewis, R. E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.5146-5148.2005 · Cited by 131
Self-citationMacCallum, D. M., Coste, A., Ischer, F., Jacobsen, M. D., Odds, F. C., & Sanglard, D. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01645-09 · Cited by 98 · cited 2×
“First, mutations in the gene encoding the drug target Erg11 alter the drug-binding domain of triazoles, reducing the potency of some, but not necessarily all triazoles.32,37 Second, high level triazole resistance may result from overexpression of genes involved in the sterol biosynthesis pathway as well as upregulatio…”
BackgroundIn-vivo selection of an azole-resistant petite mutant of Candida glabrata
BOUCHARA, J.-P., LE BOUDOUIL, S., FILMON, R., ZOUHAIR, R., HALLET, J.-N., CHABASSE, D., RENIER, G., & DEFONTAINE, A. (2000) · Journal of Medical Microbiology · doi:10.1099/0022-1317-49-11-977 · Cited by 88 · cited 1×
“glabrata, resulting in the triazole-resistant “petite mutant” growth phenotype in vitro that is resistant to triazoles.(39,40) Biofilm formation is clearly an important virulence trait and resistance mechanism for chronic or relapsing Candida infections that acts as a physical barrier protecting underlying cells from…”
BackgroundShields, R. K., Nguyen, M. H., Du, C., Press, E., Cheng, S., & Clancy, C. J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00999-10 · Cited by 65
Ben-Ami, R., & Kontoyiannis, D. P. (2012) · Virulence · doi:10.4161/viru.3.1.18886 · Cited by 39 · cited 2×
“albicans strains with homozygous FKS1 mutations had reduced catalytic activity of glucan synthase, thicker cell walls attributable to increased cell wall chitin and reduced growth rate and capacity for filamentation.(59) FKS1 mutants were hypovirulent in fly and mouse infection models, including mixed growth competiti…”
BackgroundSelf-citationBayegan, S., Majoros, L., Kardos, G., Kemény-Beke, A., Miszti, C., Kovacs, R., & Gesztelyi, R. (2010) · The Journal of Microbiology · doi:10.1007/s12275-010-9221-y · Cited by 21
Cited by
Skrzypek, M. S., Binkley, J., Binkley, G., Miyasato, S. R., Simison, M., & Sherlock, G. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw924 · Cited by 455
Vale-Silva, L., Ischer, F., Leibundgut-Landmann, S., & Sanglard, D. (2013) · Infection and Immunity · doi:10.1128/iai.00074-13 · Cited by 65
“The influence of the development of drug resistance in yeast pathogens on virulence or even the interaction with cells of the innate immune system specifically is an emerging subject (32).”
BackgroundKasper, L., Seider, K., Gerwien, F., Allert, S., Brunke, S., Schwarzmüller, T., Ames, L., Zubiria-Barrera, C., Mansour, M. K., Becken, U., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096015 · Cited by 59
Candida glabrata's recurrent infections: biofilm formation during Amphotericin B treatment
Rodrigues, C. F., Silva, S., Azeredo, J., & Henriques, M. (2016) · Letters in Applied Microbiology · doi:10.1111/lam.12600 · Cited by 21
Metadata
- Authors
- Lewis, R. E., Viale, P., & Kontoyiannis, D. P.
- Venue
- Virulence
- Publisher
- Informa UK Limited
- Published
- 2012-07
- Volume
- 3
- Issue
- 4
- Pages
- 368-376
- ISSN
- 2150-5594 (ISSN-L)
- 2150-5608
- OpenAlex
- W2007613131
- Cited by
- 46
- References
- 42
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.